ALL REPORTS

Total 47757 Records | 4776 Pages

2024-2030 Global Ganirelix Industry Research & Trends Analysis Report

2024-2030 Global Ganirelix Industry Research & Trends Analysis Report

Ganirelix acetate (or diacetate), is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilization

date 2024-03-01
industry Pharma & Healthcare

Ganirelix acetate (or diacetate), is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilization

date 2024-03-01
industry Pharma & Healthcare
2024-2030 Global Albumin Industry Research & Trends Analysis Report

2024-2030 Global Albumin Industry Research & Trends Analysis Report

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

date 2024-03-01
industry Pharma & Healthcare

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

date 2024-03-01
industry Pharma & Healthcare
Ganirelix - Global and China Top Players Market Share and Ranking 2024

Ganirelix - Global and China Top Players Market Share and Ranking 2024

Ganirelix acetate (or diacetate), is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilization

date 2024-03-01
industry Pharma & Healthcare

Ganirelix acetate (or diacetate), is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilization

date 2024-03-01
industry Pharma & Healthcare
Albumin - Global and China Top Players Market Share and Ranking 2024

Albumin - Global and China Top Players Market Share and Ranking 2024

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

date 2024-03-01
industry Pharma & Healthcare

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

date 2024-03-01
industry Pharma & Healthcare
2024-2030 Global Idiopathic Pulmonary Fibrosis (IPF) Drug Industry Research & Trends Analysis Report

2024-2030 Global Idiopathic Pulmonary Fibrosis (IPF) Drug Industry Research & Trends Analysis Report

These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in clinical trials to slow down the rate of fibrosis or scarring in the lungs. These drugs are approved for patients with mild, moderate and severe IPF.

date 2024-02-29
industry Pharma & Healthcare

These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in clinical trials to slow down the rate of fibrosis or scarring in the lungs. These drugs are approved for patients with mild, moderate and severe IPF.

date 2024-02-29
industry Pharma & Healthcare
Idiopathic Pulmonary Fibrosis (IPF) Drug - Global and China Top Players Market Share and Ranking 2024

Idiopathic Pulmonary Fibrosis (IPF) Drug - Global and China Top Players Market Share and Ranking 2024

These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in clinical trials to slow down the rate of fibrosis or scarring in the lungs. These drugs are approved for patients with mild, moderate and severe IPF.

date 2024-02-29
industry Pharma & Healthcare

These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in clinical trials to slow down the rate of fibrosis or scarring in the lungs. These drugs are approved for patients with mild, moderate and severe IPF.

date 2024-02-29
industry Pharma & Healthcare
Artificial Tears Lubricating Eye Drop - Global Top Players Market Share and Ranking 2024

Artificial Tears Lubricating Eye Drop - Global Top Players Market Share and Ranking 2024

According to YH Research, the global market for Artificial Tears Lubricating Eye Drop should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare

According to YH Research, the global market for Artificial Tears Lubricating Eye Drop should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare
2024-2030 Global Artificial Tears Lubricating Eye Drop Industry Research & Trends Analysis Report

2024-2030 Global Artificial Tears Lubricating Eye Drop Industry Research & Trends Analysis Report

According to YH Research, the global market for Artificial Tears Lubricating Eye Drop should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare

According to YH Research, the global market for Artificial Tears Lubricating Eye Drop should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare
Urokinase Powder - Global Top Players Market Share and Ranking 2024

Urokinase Powder - Global Top Players Market Share and Ranking 2024

According to YH Research, the global market for Urokinase Powder should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare

According to YH Research, the global market for Urokinase Powder should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare
2024-2030 Global Urokinase Powder Industry Research & Trends Analysis Report

2024-2030 Global Urokinase Powder Industry Research & Trends Analysis Report

According to YH Research, the global market for Urokinase Powder should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare

According to YH Research, the global market for Urokinase Powder should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

date 2024-02-28
industry Pharma & Healthcare
  • 1
  • 2
  • 3
  • 4
  • 4776
电话
CONTACT US!

We will contact you back in 24 hours.

Email: info@yhresearch.com

Send Now
Send Now